4th Quarter - Termination

CAPITOL COUNSEL LLC for P&G PHARMACEUTICALS, INC.

Firm
Client
Income
—
Expenses
—
Terminated
Oct 31, 2009

No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

S. 769 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; HR 1894 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; and HR 3590 - Patient Protection and Affordable Care Act.

LobbyistCovered position, as disclosed
ZAHRA BUCK —
SHANNON FINLEY —
SARA FRANKO —
DREW GOESL —
DENISE HENRY MORRISEY —
JOHN D RAFFAELLI —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1894 (111th), H.R. 3590 (111th), S. 769 (111th)

Medicare/Medicaid MMM

Medicare Coverage and Reimbursement issues; S. 769 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; HR 1894 - Medicare Fracture Prevention and Osteoporosis Testing Act of 2009; and HR 3590 - Patient Protection and Affordable Care Act.

LobbyistCovered position, as disclosed
ZAHRA BUCK —
SHANNON FINLEY —
SARA FRANKO —
DREW GOESL —
DENISE HENRY MORRISEY —
JOHN D RAFFAELLI —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 769 (111th), H.R. 3590 (111th), H.R. 1894 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.